SynThera Biomedical: Financial Breakdown
Decoding financial health metrics of SynThera Biomedical
Total Revenue₹9.0 Lakh-31%Prev. FY
Total Expenses₹15.0 Lakh-54%Prev. FY
Profit After Tax₹-7.0 Lakh61%Prev. FY
Total Assets₹1.4 Cr-7%Prev. FY
Net Profit Margin-0.8%41%Prev. FY
FAQs on Financials of SynThera Biomedical
No. In FY25, SynThera Biomedical reported a net loss of ₹97.0 Lakh, so it was not profitable.
SynThera Biomedical's revenue grew 383.0% year-on-year, from ₹31.6K in FY24 to ₹1.5 Lakh in FY25.
SynThera Biomedical's estimated EBITDA for FY25 was ₹-81.6 Lakh, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, SynThera Biomedical posted revenue of ₹1.5 Lakh (up 383.0% YoY) and a net loss of ₹97.0 Lakh. Explore the full financials of SynThera Biomedical here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links